MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Phase 3
Conditions
Leukemia
Myelodysplastic Syndromes
First Posted Date
2003-01-27
Last Posted Date
2010-05-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
80
Registration Number
NCT00002926
Locations
🇧🇪

Hopital Universitaire Erasme, Brussels, Belgium

🇧🇪

Cliniques Universitaires Saint-Luc, Brussels, Belgium

🇨🇿

Institute of Hematology and Blood Transfusion, Prague, Czech Republic

and more 37 locations

Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

Phase 3
Conditions
Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
First Posted Date
2003-01-27
Last Posted Date
2010-04-13
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
220
Registration Number
NCT00043134
Locations
🇬🇧

Royal South Hants Hospital, Southampton, England, United Kingdom

🇮🇹

Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome, Italy

🇩🇪

Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, Germany

and more 43 locations

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

Phase 3
Conditions
Leukemia
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2011-01-21
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
1500
Registration Number
NCT00003728
Locations
🇵🇹

Hospital Escolar San Joao, Porto, Portugal

🇵🇹

Instituto Portugues de Oncologia Centro do Porto, SA, Porto, Portugal

🇫🇷

CHR de Besancon - Hopital Saint-Jacques, Besancon, France

and more 20 locations

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: trastuzumab
Drug: CMF regimen
First Posted Date
2003-01-27
Last Posted Date
2024-03-08
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
90
Registration Number
NCT00036868
Locations
🇷🇸

Institute of Oncology and Radiology of Serbia, Belgrade, Serbia

🇫🇷

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France

🇪🇬

National Cancer Institute of Egypt, Cairo, Egypt

and more 10 locations

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Phase 2
Completed
Conditions
Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-06-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
238
Registration Number
NCT00014274
Locations
🇳🇱

Academisch Medisch Centrum at University of Amsterdam, Amsterdam, Netherlands

🇧🇪

Institut Jules Bordet, Brussels, Belgium

🇳🇱

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen, Netherlands

and more 26 locations

Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Phase 3
Completed
Conditions
Leukemia
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2013-06-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
392
Registration Number
NCT00002700
Locations
🇸🇰

Institute of Hematology & Transfusiology, University Hospital, Bratislava, Slovakia

🇧🇪

Hopital Universitaire Erasme, Brussels, Belgium

🇧🇪

Universitair Ziekenhuis Antwerpen, Edegem, Belgium

and more 41 locations

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Phase 3
Completed
Conditions
Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-06-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
608
Registration Number
NCT00022191
Locations
🇺🇸

Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States

🇺🇸

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

🇺🇸

Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States

and more 231 locations

Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Procedure: axillary lymph node dissection
Procedure: lymphoscintigraphy
Procedure: therapeutic conventional surgery
Radiation: radiation therapy
First Posted Date
2003-01-27
Last Posted Date
2013-10-29
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
4813
Registration Number
NCT00014612
Locations
🇳🇱

NIJ Smellinghe, Drachten, Netherlands

🇳🇱

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

🇫🇷

CHU de Grenoble - Hopital de la Tronche, Grenoble, France

and more 26 locations

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Biological: filgrastim
Genetic: microarray analysis
Other: laboratory biomarker analysis
Other: immunohistochemistry staining method
Procedure: biopsy
Procedure: neoadjuvant therapy
Procedure: conventional surgery
Radiation: radiation therapy
First Posted Date
2003-01-27
Last Posted Date
2013-10-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
1856
Registration Number
NCT00017095
Locations
🇬🇧

Edinburgh Cancer Centre at Western General Hospital, Edinburgh, Scotland, United Kingdom

🇵🇹

Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A., Lisbon, Portugal

🇨🇭

Inselspital Bern, Bern, Switzerland

and more 36 locations

Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma

Phase 3
Completed
Conditions
Sarcoma
First Posted Date
2003-01-27
Last Posted Date
2013-09-17
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
340
Registration Number
NCT00003052
Locations
🇩🇪

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin, Germany

🇩🇪

Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany

🇩🇪

Universitaetsklinikum Essen, Essen, Germany

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath